176 related articles for article (PubMed ID: 19785032)
1. Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich syndrome gene.
Leuci V; Gammaitoni L; Capellero S; Sangiolo D; Mesuraca M; Bond HM; Migliardi G; Cammarata C; Aglietta M; Morrone G; Piacibello W
Stem Cells; 2009 Nov; 27(11):2815-23. PubMed ID: 19785032
[TBL] [Abstract][Full Text] [Related]
2. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.
Sirven A; Ravet E; Charneau P; Zennou V; Coulombel L; Guétard D; Pflumio F; Dubart-Kupperschmitt A
Mol Ther; 2001 Apr; 3(4):438-48. PubMed ID: 11319904
[TBL] [Abstract][Full Text] [Related]
3. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells.
Cui Y; Golob J; Kelleher E; Ye Z; Pardoll D; Cheng L
Blood; 2002 Jan; 99(2):399-408. PubMed ID: 11781219
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients.
Charrier S; Dupré L; Scaramuzza S; Jeanson-Leh L; Blundell MP; Danos O; Cattaneo F; Aiuti A; Eckenberg R; Thrasher AJ; Roncarolo MG; Galy A
Gene Ther; 2007 Mar; 14(5):415-28. PubMed ID: 17051251
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells.
Woods NB; Fahlman C; Mikkola H; Hamaguchi I; Olsson K; Zufferey R; Jacobsen SE; Trono D; Karlsson S
Blood; 2000 Dec; 96(12):3725-33. PubMed ID: 11090053
[TBL] [Abstract][Full Text] [Related]
6. Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis.
Frecha C; Toscano MG; Costa C; Saez-Lara MJ; Cosset FL; Verhoeyen E; Martin F
Gene Ther; 2008 Jun; 15(12):930-41. PubMed ID: 18323794
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome.
Astrakhan A; Sather BD; Ryu BY; Khim S; Singh S; Humblet-Baron S; Ochs HD; Miao CH; Rawlings DJ
Blood; 2012 May; 119(19):4395-407. PubMed ID: 22431569
[TBL] [Abstract][Full Text] [Related]
8. Was cDNA sequences modulate transgene expression of was promoter-driven lentiviral vectors.
Toscano MG; Benabdellah K; Muñoz P; Frecha C; Cobo M; Martín F
Hum Gene Ther; 2009 Nov; 20(11):1279-90. PubMed ID: 19630517
[TBL] [Abstract][Full Text] [Related]
9. Efficient human immunodeficiency virus-based vector transduction of unstimulated human mobilized peripheral blood CD34+ cells in the SCID-hu Thy/Liv model of human T cell lymphopoiesis.
Douglas JL; Lin WY; Panis ML; Veres G
Hum Gene Ther; 2001 Mar; 12(4):401-13. PubMed ID: 11242532
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
[TBL] [Abstract][Full Text] [Related]
12. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L
Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950
[TBL] [Abstract][Full Text] [Related]
13. Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene.
Marodon G; Mouly E; Blair EJ; Frisen C; Lemoine FM; Klatzmann D
Blood; 2003 May; 101(9):3416-23. PubMed ID: 12511423
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein.
Toscano MG; Frecha C; Benabdellah K; Cobo M; Blundell M; Thrasher AJ; García-Olivares E; Molina IJ; Martin F
Hum Gene Ther; 2008 Feb; 19(2):179-97. PubMed ID: 18240968
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement.
Lotti F; Menguzzato E; Rossi C; Naldini L; Ailles L; Mavilio F; Ferrari G
J Virol; 2002 Apr; 76(8):3996-4007. PubMed ID: 11907239
[TBL] [Abstract][Full Text] [Related]
16. Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy.
Avedillo Díez I; Zychlinski D; Coci EG; Galla M; Modlich U; Dewey RA; Schwarzer A; Maetzig T; Mpofu N; Jaeckel E; Boztug K; Baum C; Klein C; Schambach A
Mol Pharm; 2011 Oct; 8(5):1525-37. PubMed ID: 21851067
[TBL] [Abstract][Full Text] [Related]
17. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.
Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A
Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830
[TBL] [Abstract][Full Text] [Related]
18. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors.
Salmon P; Kindler V; Ducrey O; Chapuis B; Zubler RH; Trono D
Blood; 2000 Nov; 96(10):3392-8. PubMed ID: 11071633
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation.
Dupré L; Marangoni F; Scaramuzza S; Trifari S; Hernández RJ; Aiuti A; Naldini L; Roncarolo MG
Hum Gene Ther; 2006 Mar; 17(3):303-13. PubMed ID: 16544979
[TBL] [Abstract][Full Text] [Related]
20. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]